Tag
#glp-1
11 studies
Weight Loss Drugs vs. Dieting: Which Shrinks Muscle More?
A new study reveals that popular weight loss drugs and standard dieting cause similar amounts of muscle loss, but one key habit can protect your lean mass.
Read AnalysisGLP-1 Drug Semaglutide Fails to Slow Early Alzheimer's
A major phase 3 trial reveals that oral semaglutide does not slow cognitive decline in patients with early-stage Alzheimer's disease.
Read AnalysisBeyond Weight Loss: What GLP-1 Drugs Do to Your Body
While GLP-1 medications are famous for treating diabetes, a massive new study reveals how they impact everything from your gut to your lungs.
Read AnalysisNew Daily Pill Outperforms Semaglutide for Blood Sugar Control
A new once-daily oral drug called orforglipron may lower blood sugar levels more effectively than oral semaglutide.
Read AnalysisSemaglutide Significantly Reduces Heavy Drinking in Clinical Trial
A landmark clinical trial reveals that the popular drug semaglutide can dramatically curb heavy drinking days in patients with alcohol use disorder.
Read AnalysisWhat Happens After You Stop Semaglutide or Tirzepatide?
A new study reveals what actually happens to patients' weight a year after discontinuing popular GLP-1 medications.
Read AnalysisNew Daily Pill Shows Promise for Diabetes and Weight
A new phase 3 trial reveals that a daily oral pill called orforglipron could provide a highly effective, injection-free alternative for managing type 2 diabetes and body weight.
Read AnalysisWomen Lose More Weight Than Men on GLP-1 Medications
A new analysis reveals that popular GLP-1 medications lead to significantly more percentage body mass reduction in women than in men.
Read AnalysisSemaglutide May Outperform Tirzepatide for Heart Health in Obesity
A new real-world study suggests semaglutide provides greater protection against major cardiovascular events than tirzepatide in overweight adults with prior heart disease.
Read AnalysisProtecting Your Muscle While Taking GLP-1 Weight Loss Drugs
While GLP-1 weight loss medications offer incredible benefits, a new review highlights the critical need to protect against accompanying muscle loss.
Read AnalysisTirzepatide Outperforms Semaglutide in Real-World Six-Month Comparison
A real-world comparison reveals that tirzepatide drives significantly greater results than semaglutide over six months.
Read Analysis